Clinical Trial Update: Compare Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two doses of palonosetron for prevention of postoperative nausea and vomiting in obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Palonosetron (palonosetron)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: COMPLETED